Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Epithalon does not appear to affect telomerase in transformed (cancer) cells, which already express constitutive telomerase activity, though this observation requires further investigation
April 14, 2022
The key pharmacological difference is duration of action: the trans-3-hexenoic acid modification extends the effective half-life, producing a more sustained and reproducible GH pulse
van WingenGvan BroekhovenFVerkesRJPeterssonKMBckstrmTBuitelaarJet al
But I also think that there are places, such as with experimental treatments like with BPC-157, we probably need to press pause on at least until theres some actual human trials that trend towards FDA approval and keep things where they are today
US$ 24.98
US$ 22.91
US$ 27.30
US$ 20.75
US$ 20.22
